Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Austin

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
The New England Journal of Medicine|August 23, 1984
Effect of treatment on the evolution of renal abnormalities in lupus nephritisJ E Balow, H A Austin, L R Muenz, et al.
Annals of Internal Medicine|October 1, 1996
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trialM F Gourley, H A Austin, D Scott, et al.
Annals of Internal Medicine|December 1, 1988
Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized studyD E Yocum, J H Klippel, R L Wilder, et al.
Rheumatology (Oxford, England)|February 24, 2007
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritisG G Illei, C H Yarboro, T Kuroiwa, et al.
Radiology|May 1, 1986
Glioblastoma: catheter techniques for isolated chemotherapy perfusionJ L Doppman, R L Dedrick, D R Shook, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Exogenous peptide and protein expression levels using retroviral vectors in human cellsT M Sandrock, B Risley, B T Richards, et al.
Annals of Internal Medicine|August 21, 2001
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritisG G Illei, H A Austin, M Crane, et al.
Clinical Nephrology|August 26, 1998
Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patientsI O Tassiulas, I Aksentijevich, J E Salmon, et al.
Arthritis and Rheumatism|April 16, 2002
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studiesG G Illei, K Takada, D Parkin, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The New England Journal of Medicine|August 23, 1984
Effect of treatment on the evolution of renal abnormalities in lupus nephritisJ E Balow, H A Austin, L R Muenz, et al.
Annals of Internal Medicine|October 1, 1996
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trialM F Gourley, H A Austin, D Scott, et al.
Annals of Internal Medicine|December 1, 1988
Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized studyD E Yocum, J H Klippel, R L Wilder, et al.
Rheumatology (Oxford, England)|February 24, 2007
Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritisG G Illei, C H Yarboro, T Kuroiwa, et al.
Radiology|May 1, 1986
Glioblastoma: catheter techniques for isolated chemotherapy perfusionJ L Doppman, R L Dedrick, D R Shook, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2001
Exogenous peptide and protein expression levels using retroviral vectors in human cellsT M Sandrock, B Risley, B T Richards, et al.
Annals of Internal Medicine|August 21, 2001
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritisG G Illei, H A Austin, M Crane, et al.
Clinical Nephrology|August 26, 1998
Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patientsI O Tassiulas, I Aksentijevich, J E Salmon, et al.
Arthritis and Rheumatism|April 16, 2002
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studiesG G Illei, K Takada, D Parkin, et al.
Pageof 7